Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Venous Thromboembolism 2Venous Thrombosis 1Thrombosis 1Sarcoma 1Pulmonary Embolism 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Fractures, Spontaneous 1Femoral Fractures 1Bone Neoplasms 1

Interventions

Standard of Care 2Proton Therapy 2Magnetic Resonance Spectroscopy 2regorafenib 1delta 24-sterol reductase 1Transcranial Direct Current Stimulation 1Surveys and Questionnaires 1Surgical Navigation Systems 1Surgery, Computer-Assisted 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Quality of Life 1Psychology, Positive 1Psychoanalysis 1Practice Guidelines as Topic 1Palliative Care 1Methods 1Masks 1Interviews as Topic 1Guanabenz 1Fitness Trackers 1Dalteparin 1Cognitive Behavioral Therapy 1Bone Plates 1Behavioral Sciences 1Arthroplasty, Replacement, Hip 1Anesthesia, Epidural 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Bone Neoplasms × Dalteparin × Clear all
NCT00525057 2021-01-22

Dalteparin in Preventing DVT in Participants With Cancer

M.D. Anderson Cancer Center

Phase NA Completed
65 enrolled 14 charts
LymphoidPlasma cellSarcoma

Bone Neoplasms, Femoral Fractures, Fractures, Spontaneous, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡